# Safety and Efficacy of J147 in Acute Ischemic Stroke

> **NCT07430917** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Abrexa Pharmaceuticals, Inc.** · enrollment: 196 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** J147 Emulsion for Injection
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07430917
- **Lead sponsor:** Abrexa Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07430917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07430917, "Safety and Efficacy of J147 in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07430917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*